Close Menu

influenza

The company will use the Phase II NIAID grant to develop flu diagnostic technologies based on University of Colorado technologies.

Nanosphere gets FDA OK for Verigene Respiratory Virus Plus NAT.

Nanosphere said that the RV+ test detects influenza A and B and respiratory syncytial virus A and B, and further subtypes flu A as H1, H3, or 2009 H1N1.

The method can be used to detect reassortments in the viral genome by analyzing large databases of influenza genomes and all segments of the viral genome.

Quest Diagnostics has received 510(k) clearance from the US Food and Drug Administration for its Focus Diagnostics Simplexa Flu A/B and RSV test on the 3M Integrated Cycler.

The Focus Diagnostics Simplexa Flu A/B & RSV test is intended to aid in the detection and discrimination of influenza A, influenza B, and respiratory syncytial virus infections.

GenturaDx has developed a molecular diagnostic system that combines sample preparation and real-time PCR testing on a disposable cartridge in an effort to bring molecular testing to more laboratories at small- and medium-sized hospitals.

The firm has licensed the new signatures that it said provide enhanced sensitivity and specificity for H1N1 specimens.

In a research paper published online this week, the scientists demonstrated that Cepheid's Xpert Flu A panel test represents "a great improvement" over methods currently employed by a majority of clinical labs to detect 2009 H1N1 influenza, but still falls a bit short when compared to the gold standard method.

The new venture also will work with Novartis on accelerating the production of influenza seed strains required for vaccine manufacturing.

Pages

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.